Dupilumab for chronic spontaneous urticaria-marvelous or meek?

J Allergy Clin Immunol. 2024 May 14:S0091-6749(24)00463-9. doi: 10.1016/j.jaci.2024.05.004. Online ahead of print.

Authors

Sameer K Mathur¹, Daniel L Rosenberg², Ravi K Viswanathan²

Affiliations

¹ Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wis. Electronic address: skmathur@wisc.edu.
² Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wis.

PMID: 38754637
DOI: 10.1016/j.jaci.2024.05.004

No abstract available

Keywords: Urticaria; dupilumab; omalizumab.

Publication types

Editorial